BMS-265246
CAS No. 582315-72-8
BMS-265246( BMS265246 | BMS-265246 | BMS 265246 )
Catalog No. M15136 CAS No. 582315-72-8
BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 102 | In Stock |
|
10MG | 177 | In Stock |
|
25MG | 350 | In Stock |
|
50MG | 530 | In Stock |
|
100MG | 759 | In Stock |
|
500MG | 1557 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-265246
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay.
-
DescriptionBMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay. It is 25-fold more selective for CDK1/2 than CDK4.
-
In VitroRT-PCR Cell Line:Calu-3 cells Concentration:9 nM Incubation Time:24 hours Result:Abrogated the ability of CHI3L1 (chitinase 3-like-1) to stimulate epithelial cells ACE2 (angiotensin converting enzyme 2) and SPP (viral spike protein priming proteases).
-
In Vivo——
-
SynonymsBMS265246 | BMS-265246 | BMS 265246
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK1/CyclinB| CDK2/CyclinE| CDK4/CyclinD
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number582315-72-8
-
Formula Weight345.34
-
Molecular FormulaC18H17F2N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL (57.91 mM)
-
SMILESO=C(C1=CN=C(NN=C2)C2=C1OCCCC)C3=C(F)C=C(C)C=C3F
-
Chemical Name(4-butoxy-1H-pyrazolo[3,4-b]pyridin-5-yl)(2,6-difluoro-4-methylphenyl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Misra RN, et al. Bioorg Med Chem Lett. 2003, 13(14), 2405-2408.
molnova catalog
related products
-
BS-181
BS-181 is a potent, selective CDK7 inhibitor with IC50 of 21 nM.
-
BI-1347
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
-
CDK12 inhibitor 2
CDK12 inhibitor 2 is a potent, selective, non-covalent CDK12 inhibitor with IC50 of 52 nM, displays >192-fold selectivity over CDK2/7/8/9.